Eurasian Harm Reduction Network - EHRN LIBRARY

Library search

Russian column on HRI website dedicated to Human Rights and Drug Policy
2011
In many countries around the world, drug control efforts result in serious human rights abuses: torture and ill treatment by police, mass incarceration, extrajudicial killings, arbitrary detention, denial of essential medicines and basic health services.
 
Marijuana: Information Sheet for professionals
STOP AIDS NGO, Albania, 2011
The Information Sheet on Marijuana for Professionals developed by STOP AIDS NGO – ALBANIA covers such topics as appearance of Marijuana, methods of use, drug class, route of administration, pharmacodynamics, pharmacokinetics, effects, side effects and health risks, tolerance, dependence and withdrawal effects, etc.
 
EMCDDA–Europol annual report outlines achievements in psychoactive substances control for 2010
European Monitoring Centre for Drugs and Drug Addiction, Europol, 2011
EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA presents the results and outlines the key achievements for 2010 on the information exchange, risk-assessment and control of new psychoactive substances.
 
International Journal of Drug Policy: review of law enforcement effect on drug market violence
International Journal of Drug Policy, 2011
The International Journal of Drug Policy (IJDP) has conducted a systematic review to examine the impacts of drug law enforcement on drug market violence.
 
WHO: Building integrated care services for injection drug users in Ukraine
World Health Organization, 2010
Building integrated care services for injection drug users in Ukraine is a World Health Organization (WHO) commissioned report aimed at examining the development of integrated care (IC) services for people with a history of injection drug use in Ukraine, as part of the country’s ongoing response to the HIV epidemic.
 
OSI presents: Harm Reduction at Work
Open Society Foundations, 2011

Harm Reduction at Work is a practical, hands-on guide written by Raffi Balian and Cheryl White, whose many years of experience in harm reduction, drug user activism, and organizational leadership have made them experts on working with people who use drugs.

 

 
WHO Policy Guidelines for Controlled Substances
World Health Organization (WHO), 2011

The new World Health Organization (WHO) policy guidelines "Ensuring balance in national policies on controlled substances. Guidance for availability and accessibility of controlled medicines" provide guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions.

 

 
IDPC Briefing Paper - Time for an Impact Assessment of Drug Policy now available in Russian
International Drug Policy Consortium (IDPC), 2010

“Time for an Impact Assessment of Drug Policy” a briefing paper by IDPC which calls for a much needed Impact Assessment of drug policy.

 
IDPC Briefing Paper - Drug policies and harm reduction in South East Europe
International Drug Policy Consortium (IDPC), 2011

“Drug policies and harm reduction in South East Europe” is a briefing paper by IDPC. This is the first of a series focusing on drug-related issues in SEE. It provides an overview of the current situation regarding harm reduction services and national drug policies in the region.

 
Analytical Report on Access of Vulnerable Groups to Prevention, Treatment, Care and Support Related to the HIV/AIDS Epidemic in Ukraine
Association of Substitution Treatment Advocates in Ukraine (ASTAU) , 2011

The report was prepared by the Association of Substitution Treatment Advocates in Ukraine within the framework of the project of the Eurasian Harm Reduction Network (EHRN) "Achieving Universal Access: Supporting Community Sector Involvement and Advocacy".

 
Open Society Institute presents Study on Swiss Drug Policy
Open Society Foundation, 2010
"From the Mountaintops: What the World Can Learn from Drug Policy Change in Switzerland", is a new report by the Open Society Foundation authored by Joanne Csete from Columbia University.
 
EMCDDA issues risk assessment report of mephedrone
EMCDDA, 2010
Risk Assessment Report of a new psychoactive substance: 4-methylmethcathinone (mephedrone) by European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) presents the summary findings and the conclusions of the risk assessment carried out by the EMCDDA’s extended Scientific Committee of the new psychoactive substance 4-methylmethcathinone (hereinafter ‘mephedrone’).
 
What can we learn from the Portuguese decriminalization of illicit drugs?
British Journal of Criminology, 2010
The paper "What can we learn from the Portuguese decriminalization of illicit drugs?" published in the British Journal of Criminology examines the case of Portugal, a nation that decriminalized the use and possession of all illicit drugs on July 1, 2001. The paper concludes that contrary to predictions, the Portuguese decriminalization did not lead to major increases in drug use. Indeed, evidence indicates reductions in problematic use, drug-related harms and criminal justice overcrowding. The article discusses these developments in the context of drug law debates and criminological discussions on late modern governance.

[In English]
 
Key HIV and Harm Reduction Interventions by International HIV/AIDS Alliance
Key HIV and Harm Reduction Interventions are series of regular HIV updates from the International HIV/AIDS Alliance. HIV update No.6 summarizes the key approaches, interventions and models of delivery used when responding to HIV and injecting drug use.

[In English]
 
New website shows what works for women and girls in HIV prevention, treatment, care and support
What Works for Women and Girls: Evidence for HIV/AIDS Interventions, now available at www.whatworksforwomen.org, is a comprehensive review of successful HIV programming for women and girls spanning data from more than 2,000 scientific articles and reports in nearly 100 countries.
 
The Lancet presents: HIV in people who use drugs series
Lancet, 2010
Almost three decades after the discovery of HIV, the Lancet issued special series to highlight the threat of a largely unpublicized and growing HIV epidemic: in people who use drugs.
 
‘Meth/amphetamine use and associated HIV: Implications for global policy and public health’, study by IJDP
International Journal of Drug Policy, 2010
Amphetamine type stimulants (ATS) have become the focus of increasing attention worldwide. There are understandable concerns over potential harms including the transmission of HIV.
 
US strategy for prevention and Control of Hepatitis B and C by the US Institute of Medicine
Institute of Medicine, 2009
A milestone in the fight against viral hepatitis in the US, the recent release of the Institute of Medicine (IOM) report, ‘Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C,’ raises the visibility of the burden of viral hepatitis and identifies priorities for research, policy, and action.
 
New HCLU film about needle exchange programs in the US

After two decades, the US Congress has voted to lift a ban on federal funding of needle exchange programs in December 2009.

 
IPF investigates financial costs of the penalization of drug possession for personal use in Poland
Institute for Public Affairs, 2009
The Institute for Public Affairs (Poland) in a report 'Penalisation of drug possession - Institutional action and costs' presents findings of an economic research estimating the financial costs of the penalization of drug possession for personal use in Poland.
 
Latin American Initiative on Drugs and Democracy presents publication about legislative innovations in drug policy
Latin American Initiative on Drugs and Democracy, 2009
Publication ‘Legislative Innovation in Drug Policy’ by Martin Jelsma (Transnational Institute) summarizes good practices in legislative reforms around the world, representing steps away from a repressive zero-tolerance model towards a more evidence-based and humane drug policy.
 
Preventing HIV infection among IDUs and other vulnerable groups in Russia: a review of regional experience
Global Business Coalition, 2009
Injecting drug use remains one of the main factors leading to spread of HIV infection and related diseases in Russia: 79.8% of the total number of HIV cases and 62.7% of the number of new cases in Russia are bound to drug injection.
 
International HIV/AIDS Alliance report: 'Civil society leads international response' in Ukraine
International HIV/AIDS Alliance, 2009
Тhe report ‘Civil society leads national response: Overcoming the HIV/AIDS epidemic in Ukraine’ introduces the Global Fund supported programme in Ukraine.
 
The Report 'Women and HIV in prison settings' now available in Russian
UNODC, UNAIDS, 2009
Despite the fact that prisons are attributed with high risk of HIV transmission, prevention programs, treatment, care and support to HIV-positive in prison settings are developed and implemented insufficiently. In addition, the situation in prisons, as a rule, do not respond to the needs of a particular sex. All existing programs and services in prisons for women were originally developed for men. In the meantime drugs and HIV infection is much more prevalent among female prisoners than male.

[In English] [In Russian]
 
Cocaine users risk getting Hepatitis C

500 million people around the world are currently infected with chronic hepatitis B or C, many don't know they have the virus. You can only contract Hepatitis C if your blood comes into contact with infected blood and people who share needles to take heroin or steroids are at the biggest risk.

 
Internet-based drug treatment interventions by EMCDDA
EMCDDA, 2009

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) presents the report on Internet-based drug treatment interventions that provides a comprehensive review of the relatively new phenomenon of Internet-based drug treatment interventions (DTI).

 
Active IDUs and those on opiate substitution treatment can have good hepatitis C therapy outcomes
HivandHepatitis.com, 2009

Active injection drug users (IDUs) and those receiving opiate substitution can be successfully treated for chronic hepatitis C virus infection, according to a French study presented at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL 2009) in March in Copenhagen.

 
Evaluation of the access to HIV/AIDS treatment and care in Latvia
WHO, 2009

The report 'Evaluation of the access to HIV/AIDS treatment and care in Latvia' was released after WHO mission was carried out to assess the situation with HIV treatment in Latvia.

 
Human Rights Abuses in the Name of Drug Treatment: Reports from the Field
OSI, IHRD, 2009
The accounts in this fact sheet, drawn from published literature and interviews with people who have passed through treatment in Asia and the former Soviet Union, detail the range of abuses practiced in the name of drug dependence treatment, and suggest the need for reform on grounds of health and human rights.
 
Report on primary prevention of Hepatitis C among injecting drug users
ACMD, 2009
The Advisory Council on the Misuse of Drugs (ACMD) is an independent expert body that advises government on drug related issues in the UK. The new ACMD report focuses on HCV prevention among injecting drug users.
 
Report ARV4IDUs in Eastern and Central Europe
EATG, 2008

As the World Health Organization (WHO) and other groups have shown, antiretroviral therapy (ART) is effective in treating injecting drug users (IDUs) for HIV – provided they receive adequate support. The effectiveness of ART has been demonstrated for both active and former IDUs, including those on opioid substitution therapy (OST). The benefits are manifold and include cost-effectively improving both individual and public health, reducing HIV transmission and honouring everyone’s right to health.

ARV4IDUs in Central and Eastern Europe - Barriers to access – and ways to overcome them
examines the barriers that Central and Eastern European IDUs face in accessing ART, and it highlights some of the ways that non-governmental organizations (NGOs) and governments have found to overcome these obstacles.


[In  English] [In Russian]

 


Harm reduction Drug policy Opioid substitution therapy
Hepatitis C Prisons HIV
Overdose Special groups Stigma & discrimination